Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Modulates the Expression of Genes Involved in Apoptosis and Cell Cycle in Human Osteoclasts
- 15 May 2007
- journal article
- research article
- Published by Wiley in The Anatomical Record
- Vol. 290 (7) , 838-845
Abstract
It has been clearly established that receptor activator of nuclear factor kappa B ligand (RANKL) is a key cytokine involved in the differentiation of osteoclastic precursors of the monocytic/macrophagic lineage. However, relatively little information is available on the ability of RANKL to modulate the expression of genes controlling cell survival/apoptosis and proliferation in human osteoclastic cells in comparison to macrophages. For this purpose, CD14+ human peripheral blood mononuclear cells, which express the cognate high affinity receptor activator of nuclear factor kappa B (RANK), were differentiated along the macrophagic or osteoclastic lineage by adding macrophage‐colony stimulating factor (M‐CSF) or M‐CSF plus RANKL in culture for 12 days. RANKL up‐regulated the expression of the chemokine MIP1α, which potentiates osteoclastic differentiation and simultaneously activated both anti‐apoptotic (Bcl‐2) and pro‐apoptotic (CIDEB, PYCARD, and BAK‐1) genes. Moreover, RANKL markedly up‐regulated cylin D2, while it significantly decreased the levels of cyclin A, cyclin‐dependent kinase 2, and other cyclin‐dependent kinases, in keeping with the notion that end‐stage osteoclasts are nondividing cells. Finally, a long‐term exposure of RANKL up‐regulated the adaptor protein TRAF3 but not TRAF6. Anat Rec, 2007.Keywords
This publication has 29 references indexed in Scilit:
- CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteinsExperimental Cell Research, 2006
- Dual promoters control the cell-specific expression of the human cell death-inducing DFF45-like effector B geneBiochemical Journal, 2006
- Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase αJournal of Biological Chemistry, 2004
- Evidence That Receptor Activator of Nuclear Factor (NF)-κB Ligand Can Suppress Cell Proliferation and Induce Apoptosis through Activation of a NF-κB-independent and TRAF6-dependent MechanismJournal of Biological Chemistry, 2004
- Osteoclast differentiation and activationNature, 2003
- Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκBJournal of Biological Chemistry, 2002
- Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in VivoThe American Journal of Pathology, 2000
- HIV Type 1 Extracellular Tat Protein Stimulates Growth and Protects Cells of BK Virus/ tat Transgenic Mice from ApoptosisAIDS Research and Human Retroviruses, 1995
- Overexpression of Cyclin D1 Blocks Proliferation of Normal Diploid FibroblastsExperimental Cell Research, 1995
- Role of colony‐stimulating factor‐1 in bone metabolismJournal of Cellular Biochemistry, 1994